Polyetherimide- and folic acid-modified Fe3 O4 nanospheres for enhanced magnetic hyperthermia performance

J Biomed Mater Res B Appl Biomater. 2023 Apr;111(4):795-804. doi: 10.1002/jbm.b.35190. Epub 2022 Nov 16.

Abstract

Recent studies have highlighted the development prospects of magnetic hyperthermia in cancer therapy. A few studies on the application of Fe3 O4 nanospheres for the magnetic hyperthermia of gynecological malignancies have achieved certain efficacy, but there was no visible progress currently. In this work, Fe3 O4 nanospheres modified with polyetherimide (PEI) and folic acid (FA) were synthesized using a hydrothermal method for possible utility in biocompatible and active tumor-targeting magnetic induction hyperthermia. The PEI- and FA-coated Fe3 O4 nanospheres showed high crystallinity, well-dispersed spherical structures and ideal Ms value. As a result, the designed Fe3 O4 @ PEI@FA nanospheres achieved higher specific absorption rate (SAR) values at 360 kHz and 308 Oe, as well as excellent biocompatibility in Hela, SKOV3, HEC-1-A and NIH3T3 cells. These nanospheres can be used as an optimal heating agent for the magnetic hyperthermia treatment of gynecological cancers.

Keywords: Fe3O4 nanospheres; anticancer therapy; magnetic hyperthermia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Folic Acid / pharmacology
  • Humans
  • Hyperthermia, Induced* / methods
  • Magnetic Phenomena
  • Mice
  • NIH 3T3 Cells
  • Nanospheres*

Substances

  • polyetherimide
  • Folic Acid